Therapeutic area

Endocrine disorders – page 36

497 clinical trials
182 recruiting
211 conditions
25 countries

Clinical trials in Endocrine disorders

497 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

497 clinical trials

Type 2 diabetes mellitus

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Oral Semaglutide Compared to Placebo in Children and Adolescents with Type 2 Diabetes Using Metformin or Basal Insulin

Registered drug

Austria

Participants:0–17 years
Substances:Semaglutide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Type 1 diabetes mellitus

Not recruiting

InvestigationalNo placebo

Study on the Safety and Feasibility of Diamyd (Glutamate Decarboxylase 2) for Individuals Aged 8-17 at Risk for Type 1 Diabetes with HLA DR3-DQ2 Haplotype

InvestigationalNo placebo

Sweden

Participants:0–17 years
Substances:Glutamate Decarboxylase 2, Human, Recombinant
Sponsor:Diamyd Medical AB

Contact Research Centre

Adrenoleukodystrophy

Not recruiting

InvestigationalNo placebo

Study on the Effects of Leriglitazone in Male Children with Cerebral X-Linked Adrenoleukodystrophy Before Stem Cell Transplant

InvestigationalNo placebo

France

Participants:0–17 years · 18–64 years
Substances:Leriglitazone
Sponsor:Minoryx Therapeutics S.L.

Contact Research Centre

Neonatal hyperglycaemia

Not recruiting

Registered drugNo placebo

Study on Oral Glibenclamide for Managing High Blood Sugar in Premature Infants Weighing Less Than 1500g

Registered drugNo placebo

France

Participants:0–17 years
Substances:Glibenclamide
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Gastroenteropancreatic neuroendocrine tumour disease

Not recruiting

Registered drugNo placebo

Study comparing 177Lu-edotreotide versus everolimus in patients with inoperable progressive neuroendocrine tumors of gastroenteric or pancreatic origin

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Everolimus
Sponsor:ITM Solucin GmbH

Contact Research Centre

Type 2 diabetes mellitus+4

Not recruiting

Registered drug

Study on the Effects of Alendronate on Bone and Blood Sugar Markers in Patients with Diabetes and Osteopenia/Osteoporosis

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Alendronate Sodium Monohydrate
Sponsor:Aalborg University Hospital

Contact Research Centre

Neuroendocrine carcinoma

Not recruiting

Registered drugNo placebo

Study of Cabozantinib and Avelumab for Patients with Advanced Neuroendocrine Tumors G3 Resistant to Standard Chemotherapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Avelumab
Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR

Contact Research Centre

Type 2 diabetes mellitus

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Gliclazide MR, Dapagliflozin, and Metformin for Patients with Type 2 Diabetes Not Well Controlled with Dapagliflozin

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Dapagliflozin
Sponsor:Institut De Recherches Internationales Servier IRIS

Contact Research Centre

Endocrine ophthalmopathy

Not recruiting

Investigational

Study of Batoclimab for Treating Patients with Active Thyroid Eye Disease

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Batoclimab
Sponsor:Immunovant Sciences GmbH

Contact Research Centre

Endocrine ophthalmopathy

Not recruiting

Investigational

Study on the Safety and Tolerability of Teprotumumab for Patients with Thyroid Eye Disease

Investigational

France

Participants:18–64 years · 65+ years
Substances:Teprotumumab
Sponsor:Horizon Therapeutics USA Inc.

Contact Research Centre

Endocrine ophthalmopathy

Not recruiting

Investigational

Study on the Safety and Efficacy of Linsitinib for Patients with Active, Moderate to Severe Thyroid Eye Disease

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Linsitinib
Sponsor:Sling Therapeutics Inc.

Contact Research Centre

Paraganglion neoplasm+3

Not recruiting

Registered drugNo placebo

Study on the Safety of Lutetium (177Lu) Oxodotreotide, L-Lysine Hydrochloride, and L-Arginine Hydrochloride in Adolescents with Neuroendocrine Tumors and PPGLs

Registered drugNo placebo

France

Participants:0–17 years
Substances:L-Arginine Hydrochloride
Sponsor:Advanced Accelerator Applications

Contact Research Centre

Substances studied in this area

The therapies tested most often in Endocrine disorders trials.

Semaglutide46 clinical trials Dapagliflozin21 clinical trials Empagliflozin14 clinical trials Sodium Chloride13 clinical trials Cisplatin12 clinical trials Etoposide12 clinical trials Metformin Hydrochloride12 clinical trials Carboplatin11 clinical trials Insulin Glargine11 clinical trials

Endocrine disorders – page 36

Conditions in this area

Clinical trials in Endocrine disorders

497 clinical trials

Type 2 diabetes mellitus

Study on the Effectiveness and Safety of Oral Semaglutide Compared to Placebo in Children and Adolescents with Type 2 Diabetes Using Metformin or Basal Insulin

Type 1 diabetes mellitus

Study on the Safety and Feasibility of Diamyd (Glutamate Decarboxylase 2) for Individuals Aged 8-17 at Risk for Type 1 Diabetes with HLA DR3-DQ2 Haplotype

Adrenoleukodystrophy

Study on the Effects of Leriglitazone in Male Children with Cerebral X-Linked Adrenoleukodystrophy Before Stem Cell Transplant

Neonatal hyperglycaemia

Study on Oral Glibenclamide for Managing High Blood Sugar in Premature Infants Weighing Less Than 1500g

Gastroenteropancreatic neuroendocrine tumour disease

Study comparing 177Lu-edotreotide versus everolimus in patients with inoperable progressive neuroendocrine tumors of gastroenteric or pancreatic origin

Type 2 diabetes mellitus+4

Study on the Effects of Alendronate on Bone and Blood Sugar Markers in Patients with Diabetes and Osteopenia/Osteoporosis

Neuroendocrine carcinoma

Study of Cabozantinib and Avelumab for Patients with Advanced Neuroendocrine Tumors G3 Resistant to Standard Chemotherapy

Type 2 diabetes mellitus

Study on the Effectiveness and Safety of Gliclazide MR, Dapagliflozin, and Metformin for Patients with Type 2 Diabetes Not Well Controlled with Dapagliflozin

Endocrine ophthalmopathy

Study of Batoclimab for Treating Patients with Active Thyroid Eye Disease

Endocrine ophthalmopathy

Study on the Safety and Tolerability of Teprotumumab for Patients with Thyroid Eye Disease

Endocrine ophthalmopathy

Study on the Safety and Efficacy of Linsitinib for Patients with Active, Moderate to Severe Thyroid Eye Disease

Paraganglion neoplasm+3

Study on the Safety of Lutetium (177Lu) Oxodotreotide, L-Lysine Hydrochloride, and L-Arginine Hydrochloride in Adolescents with Neuroendocrine Tumors and PPGLs

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.